Company Filing History:
Years Active: 2013-2022
Title: The Innovative Mind of Robert Cochran
Introduction
Robert Cochran is a notable inventor based in New York, NY (US). He has made significant contributions to the field of neuromuscular control, holding a total of 3 patents. His work focuses on developing systems and methods that enhance user interaction through neuromuscular signals.
Latest Patents
Cochran's latest patents include groundbreaking technologies such as "Systems, methods, and interfaces for performing inputs based on neuromuscular control." This patent describes a computer-implemented method that presents sensory cues via a user interface. It also involves receiving various neuromuscular signals from a wearable device, which the user generates in response to these cues. The method interprets these signals as input commands, allowing users to perform specified tasks within the interface.
Another significant patent is "Neuromuscular control of physical objects in an environment." This invention outlines methods and apparatus for controlling physical objects based on neuromuscular signals. The process includes recording signals from wearable devices, selecting a physical object, and controlling its operation based on the recorded signals.
Career Highlights
Throughout his career, Robert Cochran has worked with prominent companies such as Facebook Technologies, LLC and Meta Platforms Technologies, LLC. His experience in these organizations has allowed him to develop innovative solutions that bridge the gap between technology and human interaction.
Collaborations
Cochran has collaborated with talented individuals in the field, including Adam L. Berenzweig and Jason Reisman. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Robert Cochran's work in neuromuscular control showcases his innovative spirit and dedication to enhancing user experience through technology. His patents reflect a commitment to pushing the boundaries of what is possible in human-computer interaction.